Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 204,452,320
  • Shares Outstanding, K 539,068
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 9,080 M
  • EBITDA $ 15,447 M
  • 60-Month Beta 0.45
  • Price/Sales 5.53
  • Price/Cash Flow 11.15
  • Price/Book 23.45

Options Overview Details

View History
  • Implied Volatility 29.23% (+1.35%)
  • Historical Volatility 34.24%
  • IV Percentile 72%
  • IV Rank 31.16%
  • IV High 50.37% on 04/08/25
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 7) 10.90 (2.96%)
  • Put/Call Vol Ratio 1.03
  • Today's Volume 6,951
  • Volume Avg (30-Day) 32,118
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 101,102
  • Open Int (30-Day) 111,616
  • Expected Range 356.70 to 378.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 34 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 4.79
  • Number of Estimates 10
  • High Estimate 5.69
  • Low Estimate 4.47
  • Prior Year 4.90
  • Growth Rate Est. (year over year) -2.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
361.00 +1.83%
on 02/11/26
391.29 -6.05%
on 03/02/26
-0.20 (-0.05%)
since 02/05/26
3-Month
312.39 +17.68%
on 12/11/25
391.29 -6.05%
on 03/02/26
+37.71 (+11.43%)
since 12/05/25
52-Week
261.43 +40.61%
on 05/14/25
391.29 -6.05%
on 03/02/26
+51.03 (+16.12%)
since 03/05/25

Most Recent Stories

More News
AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , March 5, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Leerink Partners 2026 Global Healthcare Conference at 9:20 a.m. ET on Wednesday, March 11, 2026. Peter...

AMGN : 367.60 (-3.08%)
AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

THOUSAND OAKS, Calif. , March 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the second quarter of 2026. The dividend...

AMGN : 367.60 (-3.08%)
2 Profitable Stocks with Solid Fundamentals and 1 Facing Headwinds

2 Profitable Stocks with Solid Fundamentals and 1 Facing Headwinds

AMP : 472.89 (+0.85%)
GDEN : 28.68 (-0.10%)
AMGN : 367.60 (-3.08%)
Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?

Although Regeneron Pharmaceuticals has lagged the Nasdaq over the past year, analysts remain highly bullish about its prospects.

$NASX : 22,748.99 (-0.26%)
REGN : 764.93 (-2.87%)
AMGN : 367.60 (-3.08%)
Pfizer Stock: Is PFE Underperforming the Healthcare Sector?

Due to Pfizer’s underperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautious about the stock’s prospects

XLV : 153.91 (-2.00%)
AMGN : 367.60 (-3.08%)
PFE : 26.61 (-0.04%)
Is Amgen Stock Outperforming the Dow?

Although Amgen has outpaced the Dow over the past year, analysts remain cautiously optimistic about the stock’s prospects.

$DOWI : 47,954.74 (-1.61%)
GILD : 145.14 (-2.08%)
AMGN : 367.60 (-3.08%)
AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

THOUSAND OAKS, Calif. , Feb. 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 46 th Annual TD Cowen Health Care Conference at 1:10 p.m. ET on Monday, March 2, 2026. Kave Niksefat,...

AMGN : 367.60 (-3.08%)
How Is Merck & Co.'s Stock Performance Compared to Other Healthcare Stocks?

Despite Merck & Co.’s strong performance relative to its peers over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects

XLV : 153.91 (-2.00%)
MRK : 116.07 (-3.50%)
AMGN : 367.60 (-3.08%)
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down

1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down

CTOS : 6.83 (-3.26%)
AMGN : 367.60 (-3.08%)
CCO : 2.39 (unch)
1 Momentum Stock to Research Further and 2 We Avoid

1 Momentum Stock to Research Further and 2 We Avoid

PEBO : 32.35 (-1.28%)
AMGN : 367.60 (-3.08%)
FBK : 53.09 (-1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 391.69
2nd Resistance Point 384.39
1st Resistance Point 375.99
Last Price 367.60
1st Support Level 360.30
2nd Support Level 353.00
3rd Support Level 344.60

See More

52-Week High 391.29
Last Price 367.60
Fibonacci 61.8% 341.68
Fibonacci 50% 326.36
Fibonacci 38.2% 311.04
52-Week Low 261.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar